Bristol-Myers Squibb (BMY) Tops Q1 EPS by 7c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $56.70 --0%
EPS Growth %: +10.3%
Financial Fact:
Marketing, selling and administrative: 1.14B
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: +10.3%
Financial Fact:
Marketing, selling and administrative: 1.14B
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of ($4.40), $0.07 better than the analyst estimate of ($4.47). Revenue for the quarter came in at $11.9 billion versus the consensus estimate of $11.46 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Piper Sandler: 'DENTSPLY SIRONA (XRAY) most at risk; Own Manufacturers at Your Own Risk'
- Goldman Sachs Reiterates Conviction Buy Rating on Golar LNG Ltd. (GLNG)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
